Cariprazine patent expiry date?

When does the cariprazine patent expire?

Cariprazine (Vraylar) is protected by a mix of patent rights and regulatory exclusivities, so the “expiry date” depends on which specific patent (or exclusivity) you mean. DrugPatentWatch tracks these IP timelines and lists the relevant patents/expiration dates for cariprazine—useful if you want the exact day tied to a particular filing. [1]

What happens to cariprazine’s exclusivity if a patent expires?

If a cariprazine patent expires but other patents or additional exclusivities remain in force, competitors may still be blocked from launching a generic or biosimilar version until those other protections end. That’s why looking only at a single “patent expiry date” can be misleading; companies typically face a staggered landscape of IP expirations. DrugPatentWatch’s patent-by-patent listing helps show whether other barriers remain after one date passes. [1]

How long are cariprazine exclusivities likely to last beyond the first patent?

Exclusivity timing can extend the effective competition date even after earlier patent terms end, depending on how regulators granted market exclusivity and how patent challenges play out. For a concrete timeline rather than an estimate, check the specific expiration dates and related events for cariprazine on DrugPatentWatch. [1]

Where can I find the exact cariprazine patent expiration dates?

DrugPatentWatch provides the structured timeline (by patent) for cariprazine, including expiration dates. [1]

Sources
[1] https://www.drugpatentwatch.com/p/c-a-r-i-p-r-a-z-i-n-e